United Therapeutics Corporation (UTHR) United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine
United Therapeutics Corporation (NASDAQ: UTHR) FY 2026 Other Release
21 articles, transcripts, and reports
United Therapeutics Corporation (NASDAQ: UTHR) FY 2026 Other Release
United Therapeutics Corporation (NASDAQ: UTHR) Sec Form 8K
United Therapeutics Corporation (NASDAQ: UTHR) Q4 2025 Earnings Call dated Feb. 25, 2026 Corporate Participants: Harry Silvers — Head of...
United Therapeutics Corporation (NASDAQ: UTHR) FY 2026 Other Release
United Therapeutics Corporation (NASDAQ: UTHR) Sec Form 8K
United Therapeutics Corporation (NASDAQ: UTHR) FY 2026 Corporate Conference
United Therapeutics Corporation (NASDAQ: UTHR) FY 2026 Other Release
United Therapeutics Corporation (NASDAQ: UTHR) Sec Form 10K
United Therapeutics Corporation (NASDAQ: UTHR) Sec Form 8K
United Therapeutics Corporation (NASDAQ: UTHR) Q4 2025 Earnings Release